Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Sirius JV will be owned 51% by Sirius and 49% by Adani
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
The state-of-the-art commercial production plant will be built on a 95-acre site in Saarlouis, acquired at the end of 2024
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
Subscribe To Our Newsletter & Stay Updated
